BuzzSparks.org

Tioga Pharmaceuticals


Tioga Pharmaceuticals, Inc. develops therapies for the treatment of gastrointestinal diseases. Its product includes asimadoline, an orally administered small molecule therapeutic for the treatment of irritable bowel syndrome and functional...

Founded in 2005
Homepage:
Total money raised: $52M

92121 9393 Towne Centre Drive
Suite 200

San Diego
San Diego
USA CA

Phone: 858-677-6077

Updated on Apr 12, 2012
Tioga Pharmaceuticals at CrunchBase
Stuart J. M. Collinson CEO
David Urso COO
Martin Münchbach Board of Directors
Past

April, 2012

Tioga Pharmaceuticals raised $10M in a Series B round from Thomas, McNerney & Partners and Genesys Capital

Tioga Pharmaceuticals, Inc. Raises $10 Million to Advance Phase 3 Clinical Development of Asimadoline in Irritable Bowel Syndrome    tiogapharma.com

February, 2010

Tioga Pharmaceuticals raised $18M in a Series A round from Forward Ventures, New Leaf Venture Partners, BB Biotech Ventures, and Genesys Capital

Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome    tiogapharma.com

January, 2006

Tioga Pharmaceuticals raised $24M in a Series A round from Forward Ventures, New Leaf Venture Partners, and BB Biotech Ventures

Tioga¬ís Series A Round: $24M For Phase IIb Trial Of IBS Drug    tiogapharma.com

2005

Tioga Pharmaceuticals was founded in 2005